Immunization of T-cell deficient mice against polyomavirus infection using viral pseudocapsids or temperature sensitive mutants

Vaccine

Volumn 20, Issue 11-12, 2002, Pages 1571-1578

  Heidari, Shirin ^a,d   Vlastos, Andrea ^a   Ramqvist, Torbjörn ^a   Clark, Barny ^b   Griffin, Beverly E ^b   Garcia, Marie Isabelle ^c   Perez, Marie ^c   Amati, Paolo ^c   Dalianis, Tina ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b IMPERIAL COLLEGE SCHOOL OF MEDICINE   (United Kingdom)

^c SAPIENZA UNIVERSITY OF ROME   (Italy)

^d KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Immunization; Polyoma pseudocapsids; Polyoma temperature sensitive mutants

Indexed keywords

CAPSID PROTEIN; CD4 ANTIGEN; CD8 ANTIGEN; PROTEIN M17; PROTEIN VP1; RECOMBINANT DNA; TS 25; TS 3; TS 441; TS 610; UNCLASSIFIED DRUG; VIRUS ANTIGEN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL FUNCTION; CELLULAR IMMUNITY; CONTROLLED STUDY; EXPERIMENTAL ANIMAL; IMMUNIZATION; MOUSE; NONHUMAN; PAPOVAVIRUS; POLYMERASE CHAIN REACTION; POLYOMA VIRUS; PRIORITY JOURNAL; T LYMPHOCYTE; TEMPERATURE SENSITIVE MUTANT; TREATMENT OUTCOME; VIRUS CAPSID; VIRUS INFECTION; VIRUS RECOMBINANT; VIRUS STRAIN;

ANIMALS; ANTIGENS, CD4; ANTIGENS, CD8; CAPSID; CAPSID PROTEINS; IMMUNIZATION; IMMUNOLOGIC DEFICIENCY SYNDROMES; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MUTATION; POLYOMAVIRUS; POLYOMAVIRUS INFECTIONS; T-LYMPHOCYTES; TEMPERATURE; VIRAL VACCINES;

EID: 0037154719     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(01)00506-0     Document Type: Article

References (28)

1. Immunization with virus-like particles from cottontail rabbit papillomavirus (CRPV) can protect against experimental CRPV infection
2. Immune responses to polyomavirus and polyomavirus-induced tumors
3. Studies on polyomavirus persistence and polyomavirus induced tumor development in relation to the immune system
4. -/- double knockout mice do not clear polyoma virus infection
5. Polymavirinae: The viruses and their replication
6. Studies on polyomavirus
7. Cooperation of structural proteins during late events in the life cycle of polyoma virus
8. Polyomavirus major capsid protein VP1 is capable of packaging cellular DNA when expressed in the baculovirus system
9. Nuclear assembly of polyomavirus capsids in insect cells expressing the major capsid protein VP1
10. Polyoma virus pseudocapsids as efficient carriers of heterologous DNA into mammalian cells
11. Persistence and tissue distribution of DNA in normal and immunodeficient mice inoculated with polyomavirus VP1-pseudocapsid complexes or polyomavirus
12. Sustained ex vivo and in vivo transfer of a reporter gene using polyoma virus pseudocapsids
13. Enhancement by polylysine of transient but not stable expression of genes carried into cells by polyoma VP1-pseudocapsids
14. Interactions of heterologous DNA with polyoma virus major structural protein VP1a
15. A mutation in the DE-loop of the VP1 protein that prevents polyomavirus transcription and replication
16. Complementation and transformation by temperature sensitive mutants of polyomavirus
17. Cell-transforming ability of a temperature sensitive mutant of polyoma virus
18. Temperature dependent properties of cells transformed by thermo-sensitive mutant of polyoma virus
19. Induced cellular DNA synthesis by "early" and "late" temperature sensitive mutants of polyomavirus
20. Virion protein of polyoma temperature sensitive mutant: Late mutants
21. Alloreactive cytotoxic T-cells can develop and function in mice lacking both CD4 and CD8
22. Polyoma virus - A study of wild type mutant and defective DNAs
23. Polyoma DNA: A physical map
24. Male development of chromosally female mice transgenic for Sry
25. Persistence of polyomavirus in mice infected as adults differs from that observed in mice infected as newborns
26. T-cell-independent immunoglobulin G responses in vivo are elicited by live-virus infection but not by immunization with viral proteins or virus-like particles
27. Correlation of T-cell independence of antibody responses with antigen dose reaching secondary lymphoid organs: Implication for splenoctomized patients and vaccine design
28. + T-cell-independent immunoglobulin responses by inactivated influenza virus